Moreover, iNKT cells have the ability to kill CD1d-expressing tumor cells directly via the perforin/granzyme B, Fas-Fas ligand system and tumor necrosis factor-α-related apoptosis-inducing ligand (TRAIL) (23). This evidence concerns the gene GZMB and neoplasm.